2022
DOI: 10.1016/j.ijid.2022.09.028
|View full text |Cite
|
Sign up to set email alerts
|

Obstructive pneumonia caused by Gordonia bronchialis with a bronchial foreign body

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Ciprofloxacin showed excellent activity against G. bronchialis (all tested isolates in this systematic review), good oral bioavailability, and together with vancomycin, it is the most commonly used antibiotic in the treatment of infections caused by G. bronchialis . Moreover, the drug achieves an optimal concentration in bones and soft tissues even after oral administration, which is an effective treatment in the treatment of osteomyelitis and soft tissue infections ( 22 , 43 ). It has been used rarely as monotherapy, most often in combination with another anti-infective drug such as amoxicillin/clavulanate, ceftriaxone, imipenem, teicoplanin, minocycline, rifampin, and only in one case as triple antibiotic therapy with teicoplanin and rifampin, for treating various infections related to G. bronchialis as the main pathogen ( 2 , 12 , 18 , 21 , 25 ).…”
Section: Discussionmentioning
confidence: 99%
“…Ciprofloxacin showed excellent activity against G. bronchialis (all tested isolates in this systematic review), good oral bioavailability, and together with vancomycin, it is the most commonly used antibiotic in the treatment of infections caused by G. bronchialis . Moreover, the drug achieves an optimal concentration in bones and soft tissues even after oral administration, which is an effective treatment in the treatment of osteomyelitis and soft tissue infections ( 22 , 43 ). It has been used rarely as monotherapy, most often in combination with another anti-infective drug such as amoxicillin/clavulanate, ceftriaxone, imipenem, teicoplanin, minocycline, rifampin, and only in one case as triple antibiotic therapy with teicoplanin and rifampin, for treating various infections related to G. bronchialis as the main pathogen ( 2 , 12 , 18 , 21 , 25 ).…”
Section: Discussionmentioning
confidence: 99%